Nervgen Pharma Corp Stock Market Value
| NGENF Stock | USD 1.85 0.06 3.35% |
| Symbol | NervGen |
NervGen Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NervGen Pharma's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NervGen Pharma.
| 10/24/2024 |
| 11/23/2024 |
If you would invest 0.00 in NervGen Pharma on October 24, 2024 and sell it all today you would earn a total of 0.00 from holding NervGen Pharma Corp or generate 0.0% return on investment in NervGen Pharma over 30 days. NervGen Pharma Corp., together with its subsidiaries, engages in the discovery, development, and commercialization of ph... More
NervGen Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NervGen Pharma's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NervGen Pharma Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 33.14 | |||
| Value At Risk | (6.09) | |||
| Potential Upside | 6.79 |
NervGen Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NervGen Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NervGen Pharma's standard deviation. In reality, there are many statistical measures that can use NervGen Pharma historical prices to predict the future NervGen Pharma's volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.82) | |||
| Treynor Ratio | (0.12) |
NervGen Pharma Corp Backtested Returns
NervGen Pharma Corp has Sharpe Ratio of -0.0039, which conveys that the firm had a -0.0039% return per unit of risk over the last 3 months. NervGen Pharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify NervGen Pharma's Mean Deviation of 3.1, standard deviation of 4.64, and insignificant Risk Adjusted Performance to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.73, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, NervGen Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding NervGen Pharma is expected to be smaller as well. At this point, NervGen Pharma Corp has a negative expected return of -0.0183%. Please make sure to verify NervGen Pharma's kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if NervGen Pharma Corp performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.42 |
Average predictability
NervGen Pharma Corp has average predictability. Overlapping area represents the amount of predictability between NervGen Pharma time series from 24th of October 2024 to 8th of November 2024 and 8th of November 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NervGen Pharma Corp price movement. The serial correlation of 0.42 indicates that just about 42.0% of current NervGen Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.42 | |
| Spearman Rank Test | 0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
NervGen Pharma Corp lagged returns against current returns
Autocorrelation, which is NervGen Pharma otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting NervGen Pharma's otc stock expected returns. We can calculate the autocorrelation of NervGen Pharma returns to help us make a trade decision. For example, suppose you find that NervGen Pharma has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
NervGen Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If NervGen Pharma otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if NervGen Pharma otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in NervGen Pharma otc stock over time.
Current vs Lagged Prices |
| Timeline |
NervGen Pharma Lagged Returns
When evaluating NervGen Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of NervGen Pharma otc stock have on its future price. NervGen Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, NervGen Pharma autocorrelation shows the relationship between NervGen Pharma otc stock current value and its past values and can show if there is a momentum factor associated with investing in NervGen Pharma Corp.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in NervGen OTC Stock
NervGen Pharma financial ratios help investors to determine whether NervGen OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NervGen with respect to the benefits of owning NervGen Pharma security.